Residential College | false |
Status | 已發表Published |
Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression | |
Yao X.-M.3; Ye S.-D.3; Zai Z.1; Chen Y.1; Li X.-C.3; Yang G.-W.3; Wang Y.-X.2; Chen K.1 | |
2010-05-01 | |
Source Publication | Journal of Endocrinological Investigation |
ISSN | 03914097 17208386 |
Volume | 33Issue:5Pages:292-296 |
Abstract | Objective: To observe the effects of simvastatin on urinary excretion of matrix metalloproteinase-9 (MMP-9), renal expression of MMP-9, and investigate its possible renoprotective mechanisms in streptozotocin (STZ)-induced diabetic rats. Method: Twenty-four Wistar rats were divided into 3 groups: control healthy rats (group C, no.=8), untreated diabetic rats (group D, no.=8), and diabetic rats treated with simvastatin (20 mg/kg/d) (group S, no.=8). Peripheral blood glucose was tested weekly, glycosylated hemoglobin A (HbA), total cholesterol (TC), LDL cholesterol (LDL-C) levels, and urinary albumin (ALB) excretion rate as well as the urinary excretion rates of retinol-binding protein (RBP) and MMP-9 were tested at 8 week. The renal tissues of diabetic rats were obtained for evaluating kidney/body weight ratio, observing renal pathological changes by electron microscope and examining the expression of renal MMP-9 mRNA by RT-PCR. Results: There was no statistical difference on the change of peripheral blood TC and LDL-C between group C and group D. Peripheral blood glucose, HbA levels kidney/body weight ratio urinary excretion rates of ALB, RBP, and MMP-9 concurrently with the expression of renal MMP-9 mRNA were significantly higher in groups D and S compared with group C (p<0.01). Treatment with simvastatin significantly lowered peripheral blood TC, LDL-C, kidney/body weight ratio, urinary excretion rates of ALB, RBP, and MMP-9 as well as the expression of renal MMP-9 mRNA (p<0.01); however, there was no evident effect on the change of blood glucose and HbA levels between group D and group S. In addition, urinary excretion rate of MMP-9 showed positive correlations with the urinary ALB excretion and urinary RBP excretion. Pathological lesions of the glomeruli and epithelial cells foot processes (FP) was lightened by simvastatin. Conclusion: Simvastatin may has a potential therapeutic target in diabetic nephropathy, which may be partly attributed to down-regulating over-expression of MMP-9 in renal tissue. ©2010, Editrice Kurtis. |
Keyword | Diabetes Mellitus Diabetic Nephropathy Matrix Metalloproteinase-9 Simvastatin |
DOI | 10.3275/6558 |
URL | View the original |
Language | 英語English |
WOS ID | WOS:000278862200002 |
Scopus ID | 2-s2.0-77954195454 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | University of Macau |
Affiliation | 1.Anhui Provincial Hospital 2.Anhui Medical College 3.Anhui Medical University |
Recommended Citation GB/T 7714 | Yao X.-M.,Ye S.-D.,Zai Z.,et al. Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression[J]. Journal of Endocrinological Investigation, 2010, 33(5), 292-296. |
APA | Yao X.-M.., Ye S.-D.., Zai Z.., Chen Y.., Li X.-C.., Yang G.-W.., Wang Y.-X.., & Chen K. (2010). Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression. Journal of Endocrinological Investigation, 33(5), 292-296. |
MLA | Yao X.-M.,et al."Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression".Journal of Endocrinological Investigation 33.5(2010):292-296. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment